Fig. 7From: Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosisEffect of combined therapy on cell proliferation. The stromal cells from four control lungs (a) and four IPF lungs (b) were treated with 0.5 mM pirfenidone, 0.5 μM nintedanib or both drugs simultaneously. (*p < 0.05, KW test)Back to article page